Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
35 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-26 | 2020-07-23 | 109565 |
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2020-03-26 | 2020-06-18 | 109568 |
NOVO-GESIC | 325MG | TABLET | Resolved | 2020-03-26 | 2020-05-21 | 109571 |
TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-03-26 | 2020-04-23 | 109574 |
TEVA-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2020-03-26 | 2020-05-14 | 109577 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-03-26 | 2020-05-14 | 109580 |
TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2020-03-26 | 2020-05-08 | 109583 |
TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2020-03-26 | 2020-04-23 | 109586 |
TEVA-CODEINE | 30MG | TABLET | Resolved | 2020-03-26 | 2020-04-02 | 109589 |
TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2020-03-26 | 2020-04-09 | 109592 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-03-26 | 2020-08-21 | 109595 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-03-26 | 2020-06-18 | 109598 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-03-26 | 2020-04-23 | 109601 |
NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2020-03-26 | 2020-07-09 | 109604 |
TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2020-03-26 | 2020-09-10 | 109607 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-03-26 | 2020-04-09 | 109610 |
TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-03-26 | 2020-05-08 | 109613 |
TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2020-03-26 | 2020-05-08 | 109618 |
TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2020-03-26 | 2020-04-09 | 109623 |
TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Resolved | 2020-03-26 | 2020-05-29 | 109626 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |